De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics

Stephane Roche,Guangkuan Zhao,Alexis Richaud,Thomas Williamson,Michael Feig

DOI: https://doi.org/10.26434/chemrxiv-2024-phrrl

2024-05-28

Abstract:The binding affinity of antibodies to specific antigens stems from a remarkably broad repertoire of hypervariable loops known as complementarity-determining regions (CDRs). While recognizing the pivotal role of the heavy-chain 3 CDRs (CDR-H3s) in maximizing antibody-antigen affinity and specificity, the key structural determinants responsible for their adaptability to diverse loop sequences, lengths, and non-canonical structures are hitherto unknown. To address this question, we achieved a de novo synthesis of bulged CDR-H3 mimics excised from their full antibody context. CD and NMR data revealed that these stable standalone -hairpin scaffolds are well-folded and retain many of the native bulge CDR-H3 features in water. In particular, the tryptophan residue highly conserved across CDR-H3 sequences was found to extend the kinked base of these -bulges through a combination of stabilizing intramolecular hydrogen bond and CH/ interaction. The structural ensemble consistent with our NMR observations exposed the dynamic nature of residues at the base of the loop, suggesting that -bulges act as molecular hinges connecting the rigid stem to the more flexible loops of CDR-H3s. We anticipate that this deeper structural understanding of CDR-H3s will lay the foundation to inform the design of antibody drugs broadly and engineer novel CDR-H3 peptide scaffolds as therapeutics.

Chemistry

What problem does this paper attempt to address?

The paper aims to address the structure and function of the third complementarity-determining region of the heavy chain (CDR-H3) in antibodies. Specifically, the research focuses on the following aspects: 1. **Understanding the structural adaptability of CDR-H3**: Although CDR-H3 plays a crucial role in enhancing the affinity and specificity between antibodies and antigens, the specific mechanisms by which it adapts to different loop sequences, lengths, and atypical structures remain unclear. 2. **Synthesizing mimetic CDR-H3 loops**: To explore the aforementioned issues, researchers synthesized novel CDR-H3 mimetics by extracting β-bulge structures from the complete antibody environment and characterized them using circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. 3. **Revealing the role of β-bulge structures**: The study found that tryptophan residues extend the curved base of these β-bulges through stable intramolecular hydrogen bonds and CH/π interactions, thereby enhancing structural stability. 4. **Dynamic property analysis**: Conformational ensembles observed through NMR indicate that residues at the base of the loop exhibit dynamic properties, suggesting that β-bulges act as molecular hinges connecting the rigid stem and the more flexible CDR-H3 loop. In summary, this research provides a theoretical foundation for the design of antibody drugs through an in-depth understanding of the CDR-H3 structure and aids in the development of novel CDR-H3 peptide drug scaffolds.

De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics

De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics

Antibody CDR loops as ensembles in solution vs. canonical clusters from X-ray structures

CDR-H3 loop ensemble in solution – conformational selection upon antibody binding

Transitions of CDR-L3 Loop Canonical Cluster Conformations on the Micro-to-Millisecond Timescale

Antibody humanization—the Influence of the antibody framework on the CDR-H3 loop ensemble in solution

The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

Do antibody CDR loops change conformation upon binding?

Comparative Analysis of the CDR Loops of Antigen Receptors

Simple End-to-end Deep Learning Model for CDR-H3 Loop Structure Prediction

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.

Atomically accurate de novo design of single-domain antibodies

Inverse folding for antibody sequence design using deep learning

Investigating the ability of deep learning-based structure prediction to extrapolate and/or enrich the set of antibody CDR canonical forms

Accurate prediction of CDR-H3 loop structures of antibodies with deep learning

CDR L3 Loop Rearrangement Switches Multispecific SPE‐7 IgE Antibody From Hapten to Protein Binding

A Platform of ADAPTive Scaffolds: Development of CDR-H3 -Hairpin Mimics into Covalent Inhibitors of the PD1/PDL1 Immune Checkpoint.

Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability

Rational design of CXCR4 specific antibodies with elongated CDRs.

Modular design of bi- and multi-specific knob domain fusions